as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
0.19%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
60.21%
Downside
8.89%
Upside
Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.3B
EPS (TTM)
-3.7278
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-321.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $4.3B | 93.21% | NA | 0.00% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Akero Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Akero Therapeutics Inc investment value today
Current value as on today
₹1,84,016
Returns
₹84,016
(+84.02%)
Returns from Akero Therapeutics Inc Stock
₹79,185 (+79.18%)
Dollar Returns*
₹4,831 (+4.83%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $64.83
Get share price movements and forecasts by analysts on Akero Therapeutics Inc.
What analysts predicted
17.28%UPSIDE
Target Price
$64.83
Current Price
$53.63
Analyzed by
16 Analysts
Target
$64.83
Akero Therapeutics Inc target price $64.83, a slight upside of 17.28% compared to current price of $53.63. According to 16 analysts rating.
Search interest for Akero Therapeutics Inc Stock has increased by 527% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:527% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 October
Fri, 04:29 PM
-Akero agrees to a $5.2 billion takeover by Novo Nordisk, enhancing its position in metabolic treatments.
Sat, 04:08 AM
-Analyst downgrades Akero to Hold with a $58 price target amid regulatory uncertainties post-Novo acquisition.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, AKRO stock has moved up by 15.7%
Best in 1 Year
In the last 1 year, AKRO has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 113.2%
Organisation | Akero Therapeutics Inc |
Headquarters | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Andrew Cheng M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Thomas Ross | Senior VP & Head of Legal |
Mr. John J. Schembri | Senior VP & Head of Finance |
Mr. Patrick Lamy | Senior Vice President of Commercial Strategy |
Dr. Andrew Cheng M.D., Ph.D. | President, CEO & Director |
Dr. Jonathan M. Young J.D., Ph.D. | Co-Founder, Executive VP, COO & Secretary |
Mr. Scott A. Gangloff | Chief Technical Officer |
Ms. Catriona Yale | Executive VP & Chief Development Officer |
Dr. Timothy Rolph Ph.D. | Co-Founder & Chief Scientific Officer |
Mr. William R. White J.D. | Executive VP, CFO, Treasurer & Head of Corporate Development |
Akero Therapeutics Inc share price today is $53.63 as on at the close of the market. Akero Therapeutics Inc share today touched a day high of $53.9 and a low of $53.53.
Akero Therapeutics Inc share touched a 52 week high of $58.4 on and a 52 week low of $21.34 on . Akero Therapeutics Inc stock price today i.e. is closed at $53.63,which is 8.17% down from its 52 week high and 151.31% up from its 52 week low.
Akero Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akero Therapeutics Inc share’s latest price of $53.63 as on October 16, 2025 at 1:29 am IST, you will get 0.1865 shares of Akero Therapeutics Inc. Learn more about
fractional shares .
Akero Therapeutics Inc stock has given 93.21% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?